Select language:

EpiVacCorona protects the elderly from coronavirus by 94%

 / Главная / Russkiy Mir Foundation / News / EpiVacCorona protects the elderly from coronavirus by 94%

EpiVacCorona protects the elderly from coronavirus by 94%


07.04.2021

Photo credit: M. Mishin. Press service of the Mayor and Government of Moscow / mos.ru (CC BY 4.0)

Vaccination with EpiVacCorona among the elderly leads to the development of antibodies in 94% of cases, RIA Novosti reports.

The Vector center, which developed the drug, was assured that it can be used for all age categories over 18 years old. Now the center is studying the issue of using the drug for younger people.

EpiVacCorona, made on the basis of peptide antigens, was registered by the Vector Center from Novosibirsk in mid-October. It demonstrated 100% efficiency.

The vaccine is characterized by the highest degree of safety due to the technology of its production. There is no live virus in it, it forms antiviral immunity through the use of artificially synthesized peptides.

It clarifies that the drug has 100% effectiveness against severe cases of COVID-19 and hospitalization. Also, the results of the analysis say that the volunteers who were vaccinated did not have severe cases of COVID-19, the drug itself was well tolerated.

Russkiy Mir

News by subject

Publications

Marco Maggi: ”Russian to the Bone" 20.01.2024
Italian entrepreneur Marco Maggi's book, "Russian to the Bone," is now accessible for purchase in Italy and is scheduled for release in Russia in the upcoming months. In the book, Marco recounts his personal odyssey, narrating each stage of his life as a foreigner in Russia—starting from the initial fascination to the process of cultural assimilation, venturing into business, fostering authentic friendships, and ultimately, reaching a deep sense of identifying as a Russian at his very core.